Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 5 of 5
Full-Text Articles in Medicine and Health Sciences
Development Of A Real-Time Reverse-Transcription Pcr For Sars Cov-2 On The Luminex Aries® Platform, Subathra Marimuthu, Holly Aliesky, Brigid Connelly, Danial Arsalan Malik, Leslie A Wolf
Development Of A Real-Time Reverse-Transcription Pcr For Sars Cov-2 On The Luminex Aries® Platform, Subathra Marimuthu, Holly Aliesky, Brigid Connelly, Danial Arsalan Malik, Leslie A Wolf
The University of Louisville Journal of Respiratory Infections
The University of Louisville Infectious Diseases Laboratory followed the US Food and Drug Administration (FDA) Emergency Use Authorization (EUA) guidance for developing a molecular diagnostic test for SARS CoV-2 to help address the novel coronavirus pandemic. As a Clinical Laboratory Improvement Amendment ‘88 (CLIA) certified, high-complexity clinical laboratory, the Infectious Diseases Laboratory chose to use the Luminex ARIES® platform to evaluate a laboratory developed test. This instrument was already familiar to the Infectious Diseases Laboratory and in use for molecular diagnostic testing for pathogens causing atypical pneumonia and two tick-borne pathogens. The FDA EUA guidance for molecular diagnostic tests …
International Respiratory Infections Society Covid Research Conversations: Podcast 3 With Dr. Antoni Torres, Julio A. Ramirez, Antoni Torres
International Respiratory Infections Society Covid Research Conversations: Podcast 3 With Dr. Antoni Torres, Julio A. Ramirez, Antoni Torres
The University of Louisville Journal of Respiratory Infections
Section(s) Topics
1–4 Introductions
5 “Spanish” influenza
6–9 Dr. Torres’ personal thoughts and experiences
10 COVID-19 hospitalizations in Barcelona
11 A threatening phone call
12–13 Origin of the CIBERESUCICOVID project
14 Baseline characteristics
15 Bloodwork at hospital admission; ICU admission vs. day 3
16 Treatments
17 Complications
18 Outcomes related to interventions
19 Viral RNA load in plasma associated with critical illness and dysregulated response
20 Follow-up with health care workers
21 Medical education
22 Conclusions
23–26 Interleukin 6
27–29 Ventilatory approach
30–33 Post-COVID syndrome
34–38 Impact on health care workers
39–41 Holidays and COVID-19 infection
42–43 New paradigm for …
International Respiratory Infections Society Covid Research Conversations: Podcast 2 With Dr. Michael S. Niederman And Dr. Edward J. Schenck, Julio A. Ramirez, Michael S. Niederman, Edward J. Schenck
International Respiratory Infections Society Covid Research Conversations: Podcast 2 With Dr. Michael S. Niederman And Dr. Edward J. Schenck, Julio A. Ramirez, Michael S. Niederman, Edward J. Schenck
The University of Louisville Journal of Respiratory Infections
Section(s) Topics
1–4 Introductions
5 COVID-19 in New York City
6–7 Telemedicine, long-term sequelae
8 Development of a multi-disciplinary ICU team
9–10 Treatment of ARDS, COVID-19 pathogenesis
11–12 Prioritizing treatment at research
13 Challenges in tracing the natural history of severe COVID-19
14–15 Experience with mechanically ventilated patients; non-pulmonary organ failure
16–17 Mapping COVID-19 trajectories by SOFA score
18–20 Findings: additive organ dysfunction, improving vs. worsening trajectory
21 ARDS therapeutic approaches
22 Clinical trials involving Cornell
23–25 Lessons learned: patient care, research, education, caring for critical care workers
26–30 2021 predictions: improved therapies and research, endemic COVID-19, vaccines
31–33 Prioritizing …
International Respiratory Infections Society Covid Research Conversations: Podcast 1 With Dr. Francesco Blasi, Julio A. Ramirez Md, Francesco Blasi Md, Phd
International Respiratory Infections Society Covid Research Conversations: Podcast 1 With Dr. Francesco Blasi, Julio A. Ramirez Md, Francesco Blasi Md, Phd
The University of Louisville Journal of Respiratory Infections
Section(s) Topics
1–2 Introductions
3 Foundations of best practice
4 COVID-19 as stimulus for innovation
5 Adapting and evolving therapeutic approach
6 Age and comorbidities as risk factors
7 Over-capacity ICU
8 Adapting the ER for COVID-19
9 Training personnel for COVID-19
10 Psychological support, healthcare heroes, and COVID fatigue
11 Increased oxygen requirement
12–13 Milan’s multi-disciplinary unit
14 Standardizing respiratory support measures
15 Nutrition, sedation, and life support
16 CPAP successes and failures
17 Prone and lateral positioning of patients on CPAP
18 Different COVID-19 phenotypes?
19 Thromboembolism risk score, age, and comorbidities
20 Cardiorespiratory considerations: hypertension, echocardiography
21 …
An Update On The Leading Covid-19 Vaccines, Ahmed A. Eladely, Javaria Anwer Mbbs, Ashwini Gotimukul Mbbs, Manish Kc Mbbs, Jessica Petrey Msls, Alex Glynn Ma, Ruth M. Carrico Phd, Dnp, Julio A. Ramirez Md
An Update On The Leading Covid-19 Vaccines, Ahmed A. Eladely, Javaria Anwer Mbbs, Ashwini Gotimukul Mbbs, Manish Kc Mbbs, Jessica Petrey Msls, Alex Glynn Ma, Ruth M. Carrico Phd, Dnp, Julio A. Ramirez Md
The University of Louisville Journal of Respiratory Infections
We reviewed the COVID-19 vaccines that reached phase III of clinical development. For each of the 10 vaccines identified, we described the technology used for vaccine development, the available data from phase III clinical trials, data on vaccine safety, and the role of new SARS-CoV-2 variants on vaccine efficacy.